Japan will allow hospitals to administer Pfizer Inc.'s COVID-19 vaccine using insulin syringes, which can extract seven shots per vial rather than the five possible with the type of syringe the government has procured, health minister Norihisa Tamura said Tuesday.The move comes as the country's vaccine rollout grapples with a supply shortage owing to production delays at Pfizer's factory in Belgium and export controls by the European Union.Taro Kono, minister in charge of the country's vaccination efforts, said the government will look into procuring insulin syringes "if there is a surplus"…READ FULL ARTICLE